These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world]. Poli A; Menotti A G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121 [No Abstract] [Full Text] [Related]
46. Do statin drugs lower the risk of stroke? Sabharwal M; Por CP; Evans MF Can Fam Physician; 1998 May; 44():1003-4. PubMed ID: 9612584 [No Abstract] [Full Text] [Related]
47. [The simvastatin study--was the consumption of wine considered?]. Rasmusson BU Ugeskr Laeger; 1995 Aug; 157(33):4585. PubMed ID: 7645108 [No Abstract] [Full Text] [Related]
48. The statin trials: closing arguments in the case against cholesterol? Gaw A Scott Med J; 1996 Aug; 41(4):99-100. PubMed ID: 8873306 [No Abstract] [Full Text] [Related]
49. [Primary and secondary prevention of coronary disease by statins]. Ferrières J Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337 [TBL] [Abstract][Full Text] [Related]
50. Misconceptions about cholesterol. French J; White H N Z Med J; 1990 Jan; 103(882):19-20. PubMed ID: 2304673 [No Abstract] [Full Text] [Related]
52. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003 [TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain. Plans-Rubió P Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391 [TBL] [Abstract][Full Text] [Related]
54. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]
55. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Haffner SM Diabetes Care; 1997 Apr; 20(4):469-71. PubMed ID: 9096961 [No Abstract] [Full Text] [Related]
56. Doctors, research funds and marketing. Colquhoun DM Med J Aust; 1995 Jun; 162(12):670, 672. PubMed ID: 7603388 [No Abstract] [Full Text] [Related]
57. The 4S study and its pharmacoeconomic implications. Reckless JP Pharmacoeconomics; 1996 Feb; 9(2):101-5. PubMed ID: 10172696 [No Abstract] [Full Text] [Related]
58. Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia. Cutler N; Sramek J; Veroff A; Block G; Stauffer L; Lines C Br J Clin Pharmacol; 1995 Mar; 39(3):333-6. PubMed ID: 7619678 [TBL] [Abstract][Full Text] [Related]